Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02971904
Other study ID # DanoneELN-02
Secondary ID
Status Completed
Phase N/A
First received November 21, 2016
Last updated July 25, 2017
Start date August 2015
Est. completion date June 2017

Study information

Verified date July 2017
Source Danone Early Life Nutrition Brazil
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

An observational and prospective study involving about 30 healthy lactating mothers whose preterm infant(s) is/are hospitalized at Neonatal Intensive Care Unit after childbirth and who can provide enough maternal milk (3mL) to be analyzed from 4th day of admission until 15th day of hospitalization or until discharge.

Considering the lack of evidence related to breast milk nutritional composition from Brazilian lactating mothers of preterm infants; and also the utilization of human milk analyzer as a tool to optimize nutritional therapy and reach proper growth and development of preterm babies, this study aim to evaluate the nutritional composition of human milk from lactating mothers of preterm infant during the hospitalization, the infant grow and also the applicability of mid infrared (MIR) human milk analyzer (HMA) as a methodology.


Description:

This is an observational and prospective study involving approximately 30 healthy lactating mothers whose preterm infant(s) is/are hospitalized at Neonatal Intensive Care Unit from the Hospital Santa Casa de Misericordia after childbirth. Lactating mothers should have enough milk to provide enough maternal milk their infant(s) require plus additional collection of samples (3mL). After consenting to the study, milk from lactating mothers of preterm infants in the local ICU will be analyzed daily from the moment they express sufficient milk volume beyond their child's requirement until discharge (from 4th day of admission until 15th day of hospitalization ). Three mL of sample milk will be collected every morning and analyzed, according to hospital routine. Characteristics of subjects and details of their premature children, such as gestational age, birth weight (BMI) and birth details (causes of preterm birth, delivery, complications, etc) will be collected by applying a questionnaire on the first day of analysis. The nutritional composition of the last meal before the milk sample collection and also a three no consecutive nutrition questionnaire daily intake will be evaluated.

The determination of the macronutrient content will be made from the use of Human Milk Analyzer MIRIS (MIRIS HMA), Uppsala, Switzerland, properly calibrated. The analyzer is based on the adopted infrared (IR) technology in combination with a patented technology. Sample collection, storage and analysis, as well as equipment conservation, will be carefully followed according to MIRIS protocol. Information about effectiveness, feasibility and equipment costs will also be evaluated. The data obtained by the HMA will be compared to the nutritional composition of human milk and nutritional needs of preterm found in the literature and included in the main guidelines


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date June 2017
Est. primary completion date August 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Healthy mothers with hospitalized preterm newborns

- Enough milk to breastfeed their child and donate 3 ml / day for the study

- Being the first sample of milk collected from the 4th day of hospitalization.

Exclusion Criteria:

- Mothers who are not breastfeeding

- Do not have enough milk for collection.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
human milk collection


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Danone Early Life Nutrition Brazil Irmandade da Santa Casa de Misericordia de Sao Paulo

Outcome

Type Measure Description Time frame Safety issue
Primary evolution of the nutritional composition of maternal milk of mothers of premature infants Maternal milk energy and protein daily analysis by MIRIS (Mid infrared Human Milk Analyzer) up to six months
Secondary Impact of mother´s diet in the milk composition Maternal diet questionnaire in admission and daily last meal record before every human milk collection up to six months
See also
  Status Clinical Trial Phase
Completed NCT02785926 - Impact of Antenatal Exposure to Pesticides on Neurophysiological Functions (Sleep, Respiration) of Preterm Neonates
Completed NCT01946971 - Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER) Phase 1/Phase 2
Completed NCT01530360 - Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants Phase 1
Completed NCT00681018 - Feeding Study in Premature Infants N/A
Completed NCT00217191 - Ibuprofen and Renal Function in Premature Infants Phase 4
Completed NCT01077271 - Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA N/A
Completed NCT00282113 - Effects of Probiotic and Prebiotic Combinations on Premature Infants N/A
Active, not recruiting NCT02943746 - Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants N/A
Completed NCT01994954 - A Randomized Trial of Outpatient Oxygen Weaning Strategies in Premature Infants N/A
Completed NCT00389909 - Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants Phase 4
Completed NCT00747591 - Urine Concentration of S100B in Extremely Premature Infants N/A
Recruiting NCT04555590 - Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants N/A
Completed NCT06352047 - The Effects of Positioning After Extubation of Preterm Infants on the Respiratory Functions N/A
Completed NCT03217045 - Nutrition Protocol and Premature Infants' Growth
Recruiting NCT03552952 - Development of Preterm Infant Gut Microbiome
Recruiting NCT06332521 - Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment
Completed NCT04659083 - How NAVA Works in Preterm Infants With Irregular Respiratory Efforts
Completed NCT05807191 - The Effect of Using Clinical Guidelines on Kangaroo Care on Newborn and Maternal Outcomes N/A
Completed NCT03914690 - Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage Phase 2
Completed NCT01140243 - Infant Formula Supplemented With a Special Fat Formulation for Premature Infants Following Discharge From Hospital N/A